Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 AUD | +4.17% | 0.00% | -13.79% |
27/02 | Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
2023 | Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
Sales 2022 | 22.96M 15.09M 1.26B | Sales 2023 | 24.74M 16.26M 1.36B | Capitalization | 14.86M 9.77M 814M |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | -4M -2.63M -219M | EV / Sales 2022 | 0.64 x |
Net cash position 2022 | 6.27M 4.12M 344M | Net cash position 2023 | 5.3M 3.48M 290M | EV / Sales 2023 | 0.39 x |
P/E ratio 2022 |
-30
x | P/E ratio 2023 |
-3.67
x | Employees | 30 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.26% |
1 day | +4.17% | ||
Current month | +8.70% | ||
1 month | +4.17% | ||
3 months | -19.35% | ||
6 months | -3.85% | ||
Current year | -13.79% |
Managers | Title | Age | Since |
---|---|---|---|
Star Zhang
FOU | Founder | - | 01/04/01 |
Su Zhang
CEO | Chief Executive Officer | - | - |
James Ni
DFI | Director of Finance/CFO | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Allely
CHM | Chairman | 69 | - |
Star Zhang
FOU | Founder | - | 01/04/01 |
Su Zhang
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
-13.79% | 10.6M | |
-.--% | 843M | |
-1.57% | 648M | |
+5.12% | 383M | |
+21.31% | 226M | |
-.--% | 141M | |
+117.39% | 59.32M |
- Stock Market
- Equities
- S66 Stock